Small Cell Lung Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Phase II Study Assessing the Efficacy of Etoposide Free Chemotherapy Plus Durvalumab (MEDI4736) in First Line Extensive Disease Small Cell Lung Cancer (SCLC)
Condition: Small Cell Lung Cancer Extensive Stage Intervention: Drug: Carboplatin + Paclitaxel + Durvalumab Sponsor: Intergroupe Francophone de Cancerologie Thoracique Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2023 Category: Research Source Type: clinical trials
A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC
Condition: SCLC Interventions: Drug: PM8002; Drug: Platinum; Drug: Atezolizumab; Drug: Etoposide Sponsor: Biotheus Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
